Piflufolastat F-18 Injection
Product Images NDC 85347-001

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Piflufolastat F-18 (NDC 85347-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphelion Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Piflufolastat F18 01)

Chemical structure of piflufolastat F-18, showing the molecular composition and arrangement, including the fluorine-18 radioisotope used in the compound.*

FDA Label Image

Principal Display Panel (50 mL Vial Label)

Label for PYLARIFY TRUVU (piflufolastat F-18) Injection, a diagnostic intravenous drug with a strength of 37 MBq/mL to 4,440 MBq/mL (1 mCi/mL to 120 mCi/mL) at end of synthesis. The label indicates it is a multiple-dose vial, non-pyrogenic, and includes handling cautions for radioactive material. Manufactured by Aphelion LLC with NDC 85347-001-01, the label highlights storage conditions and detailed batch, activity, and expiration information fields.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.